 | Up a level |
Colombo, Nicoletta; Biagioli, Elena; Harano, Kenichi; Galli, Francesca; Hudson, Emma; Antill, Yoland; Choi, Chel Hun; Rabaglio, Manuela; Marmé, Frederic; Marth, Christian; Parma, Gabriella; Fariñas-Madrid, Lorena; Nishio, Shin; Allan, Karen; Lee, Yeh Chen; Piovano, Elisa; Pardo, Beatriz; Nakagawa, Satoshi; McQueen, John; Zamagni, Claudio; ... (2024). Atezolizumab and chemotherapy for advanced or recurrent endometrial cancer (AtTEnd): a randomised, double-blind, placebo-controlled, phase 3 trial. The Lancet. Oncology, 25(9), pp. 1135-1146. Elsevier 10.1016/S1470-2045(24)00334-6
